The Conserved LncRNA DIO3OS Restricts Hepatocellular Carcinoma Stemness by Interfering with NONO‐Mediated Nuclear Export of ZEB1 mRNA
Advanced Science · 2023-08 · 10 (23)
DOI: 10.1002/advs.202301983 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 04.06.2023. Verfasst von Ya-Rui Hou und 9 weiteren Autor:innen. Beteiligte Einrichtung: Biotherapy Center, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, P. R. China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, RNA, Long Noncoding, Liver Neoplasms. Die Arbeit wurde bisher 29-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China, Program for Guangdong Introducing Innovative and Entrepreneurial Teams, Natural Science Foundation of Guangdong.
Abstract (Originalsprache)
Hepatocellular carcinoma (HCC) is an aggressive and fatal disease caused by a subset of cancer stem cells (CSCs). It is estimated that there are approximately 100 000 long noncoding RNAs (lncRNAs) in humans. However, the mechanisms by which lncRNAs affect tumor stemness remain poorly understood. In the present study, it is found that DIO3OS is a conserved lncRNA that is generally downregulated in multiple cancers, including HCC, and its low expression correlates with poor clinical outcomes in HCC. In in vitro cancer cell lines and an in vivo spontaneous HCC mouse model, DIO3OS markedly represses tumor development via its suppressive role in CSCs through downregulation of zinc finger E‐box binding homeobox 1 (ZEB1). Interestingly, DIO3OS represses ZEB1 post‐transcriptionally without affecting its mRNA levels. Subsequent experiments show that DIO3OS interacts with the NONO protein and restricts NONO‐mediated nuclear export of ZEB1 mRNA. Overall, these findings demonstrate that the DIO3OS‐NONO‐ZEB1 axis restricts HCC development and offers a valuable candidate for CSC‐targeted therapeutics for HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biotherapy Center, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, P. R. China.
- School of Life Sciences and Biopharmaceutics, Guangdong Pharmaceutical University, Guangzhou, 510006, P. R. China.
- Guangdong Key Laboratory of Liver Disease Research, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, P. R. China.
- Institute of Vaccine, The Third Affiliated Hospital, Sun Yat-sen University, Guangzhou, 510630, P. R. China.
ORCID-Profile: Zhen-Dong Xiao
Förderung
- National Natural Science Foundation of China
- Program for Guangdong Introducing Innovative and Entrepreneurial Teams
- Natural Science Foundation of Guangdong
- Guangzhou Science and Technology Plan Project
- Natural Science Foundation of Guangdong Province
Zitieren
APA
Hou, Y. R., Diao, L. T., Hu, Y. X., Zhang, Q. Q., Lv, G., Tao, S., Xu, W. Y., Xie, S. J., Zhang, Q., & Xiao, Z. D. (2023). The Conserved LncRNA DIO3OS Restricts Hepatocellular Carcinoma Stemness by Interfering with NONO‐Mediated Nuclear Export of ZEB1 mRNA. Advanced Science, 10(23). https://doi.org/10.1002/advs.202301983
Vancouver
Hou YR, Diao LT, Hu YX, Zhang QQ, Lv G, Tao S, et al. The Conserved LncRNA DIO3OS Restricts Hepatocellular Carcinoma Stemness by Interfering with NONO‐Mediated Nuclear Export of ZEB1 mRNA. Advanced Science. 2023;10(23). doi:10.1002/advs.202301983
BibTeX
@article{Hou2023,
author = {Hou, Ya-Rui and Diao, Li-Ting and Hu, Yan-Xia and Zhang, Qian-Qian and Lv, Guo and Tao, Shuang and Xu, Wan-Yi and Xie, Shu-Juan and Zhang, Qi and Xiao, Zhen-Dong},
title = {The Conserved LncRNA DIO3OS Restricts Hepatocellular Carcinoma Stemness by Interfering with NONO‐Mediated Nuclear Export of ZEB1 mRNA},
journal = {Advanced Science},
year = {2023},
volume = {10},
number = {23},
doi = {10.1002/advs.202301983}
}
EUVIMED